Medicare Enrolled

Dr. Elena Kozochonok, M.D

Neurology · Lemoyne, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
550 N 12TH ST, Lemoyne, PA 17043
7179758585
In practice since 2013 (12 years)
NPI: 1437580412 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kozochonok from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kozochonok? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kozochonok

Dr. Elena Kozochonok is a neurology specialist in Lemoyne, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kozochonok performed 446 Medicare services across 368 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kozochonok received a total of $7,871 from 32 pharmaceutical and/or device companies across 365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kozochonok is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 34% volume in PA $7,871 industry payments

Medicare Practice Summary

Medicare Utilization ↗
446
Medicare services
Top 34% in PA for neurology
368
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
131 $91 $225
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
114 $80 $283
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
91 $96 $304
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
40 $42 $126
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $114 $370
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
19 $51 $157
New patient office visit, complex (60-74 min) 13 $132 $489
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $43 $127
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,871
Total received (2018-2024)
Avg $1,124/year across 7 years
Top 24% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
365
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,228 (91.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$493 (6.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,452
2023
$2,229
2022
$2,001
2021
$1,283
2020
$312
2019
$262
2018
$333

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$404
Lundbeck LLC
$231
Teva Pharmaceuticals USA, Inc.
$180
LivaNova USA, Inc.
$165
EMD Serono, Inc.
$135
E.R. Squibb & Sons, L.L.C.
$92
Otsuka America Pharmaceutical, Inc.
$42
Biogen, Inc.
$41
Novartis Pharmaceuticals Corporation
$34
SK Life Science, Inc.
$28
ARGENX US, INC.
$21
GENZYME CORPORATION
$21
Sumitomo Pharma America, Inc.
$20
PFIZER INC.
$20
Celgene Corporation
$20
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,556
Celgene Corporation
$1,263
Lundbeck LLC
$604
Teva Pharmaceuticals USA, Inc.
$554
EMD Serono, Inc.
$548
GENZYME CORPORATION
$536
LivaNova USA, Inc.
$479
Allergan, Inc.
$302
E.R. Squibb & Sons, L.L.C.
$257
AbbVie Inc.
$205
Novartis Pharmaceuticals Corporation
$181
Lilly USA, LLC
$161
Biogen, Inc.
$151
Eli Lilly and Company
$150
SK Life Science, Inc.
$117
Allergan Inc.
$112
Biohaven Pharmaceutical Holding Company Ltd.
$88
ARGENX US, INC.
$73
Biohaven Pharmaceuticals, Inc.
$68
Amgen Inc.
$59
Sunovion Pharmaceuticals Inc.
$57
PFIZER INC.
$57
Sumitomo Pharma America, Inc.
$44
Otsuka America Pharmaceutical, Inc.
$42
ACADIA Pharmaceuticals Inc
$37
Medtronic USA, Inc.
$35
Eisai Inc.
$25
Amneal Pharmaceuticals LLC
$25
Janssen Pharmaceuticals, Inc
$24
Avion Pharmaceuticals
$24
Genentech USA, Inc.
$19
CSL Behring
$18
Top 3 companies account for 43.5% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Dhivy · EMGALITY · Enspryng · Hizentra · KESIMPTA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · PLEGRIDY · QULIPTA · RYTARY · TYSABRI · UBRELVY · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · XCOPRI · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Lemoyne?
Compare neurologists in the Lemoyne area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
83
Per 100K population
31.4
County median income
$85,634
Nearest hospital
PENN STATE HEALTH HOLY SPIRIT MEDICAL CENTER
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kozochonok is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kozochonok experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kozochonok performed 131 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kozochonok receive payments from pharmaceutical companies?
Yes. Dr. Kozochonok received a total of $7,871 from 32 companies across 365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kozochonok's costs compare to other neurologists in Lemoyne?
Dr. Kozochonok's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kozochonok) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →